Abingdon, United Kingdom

Stephen Johnstone

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Syntaxin Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Johnstone. Retrieved from https://idiyas.com/inventor/stephen-johnstone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen Johnstone

Introduction

Stephen Johnstone is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of neuroendocrine disease treatment. His innovative approach focuses on utilizing non-cytotoxic proteases to target neuroendocrine tumor cells.

Latest Patents

Johnstone holds a patent for the "Suppression of neuroendocrine diseases." This invention relates to a method for suppressing neuroendocrine diseases through the use of a non-cytotoxic protease. The therapy is designed to target neuroendocrine tumor cells via various receptors, including somatostatin, GHRH, and ghrelin receptors. When delivered, the protease is internalized, inhibiting secretion from the tumor cells. Additionally, the invention encompasses polypeptides and nucleic acids for use in these methods. He has 1 patent to his name.

Career Highlights

Throughout his career, Johnstone has worked with prominent companies in the biotechnology sector. He has been associated with Syntaxin Limited and Ipsen Bioinnovation Limited, where he contributed to advancements in medical therapies.

Collaborations

Johnstone has collaborated with notable professionals in his field, including Philip Marks and Keith Foster. Their combined expertise has furthered the development of innovative solutions in neuroendocrine disease treatment.

Conclusion

Stephen Johnstone's work in the suppression of neuroendocrine diseases showcases his commitment to advancing medical science. His innovative methods and collaborations highlight the importance of targeted therapies in treating complex health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…